Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Boston Scientific Corp (BSX)

Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 129,207,136
  • Shares Outstanding, K 1,467,096
  • Annual Sales, $ 14,240 M
  • Annual Income, $ 1,591 M
  • EBIT $ 3,313 M
  • EBITDA $ 4,567 M
  • 60-Month Beta 0.80
  • Price/Sales 8.94
  • Price/Cash Flow 29.77
  • Price/Book 6.18

Options Overview Details

View History
  • Implied Volatility 31.18% ( +2.10%)
  • Historical Volatility 11.92%
  • IV Percentile 98%
  • IV Rank 82.64%
  • IV High 34.64% on 10/11/24
  • IV Low 14.68% on 08/13/24
  • Put/Call Vol Ratio 0.49
  • Today's Volume 35,271
  • Volume Avg (30-Day) 6,037
  • Put/Call OI Ratio 1.33
  • Today's Open Interest 203,637
  • Open Int (30-Day) 211,355

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 28 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 0.58
  • Number of Estimates 12
  • High Estimate 0.59
  • Low Estimate 0.58
  • Prior Year 0.50
  • Growth Rate Est. (year over year) +16.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
82.59 +6.61%
on 09/26/24
88.79 -0.83%
on 10/21/24
+4.13 (+4.92%)
since 09/20/24
3-Month
71.88 +22.50%
on 08/05/24
88.79 -0.83%
on 10/21/24
+10.49 (+13.53%)
since 07/19/24
52-Week
49.15 +79.16%
on 10/27/23
88.79 -0.83%
on 10/21/24
+38.00 (+75.92%)
since 10/20/23

Most Recent Stories

More News
Cencora Rallies 14.7% Year to Date: What's Driving the Stock?

Cencora, Inc. COR witnessed strong momentum in the year-to-date period. Shares of the company have rallied 14.7% compared with 2.8% growth of the industry. The S&P 500 Composite has risen 22.5% during...

BSX : 88.05 (-0.02%)
COR : 236.54 (-0.37%)
BAX : 36.57 (-0.79%)
DVA : 161.54 (-0.27%)
Nasdaq Futures Climb on Netflix Boost, U.S. Housing Data and Fed Speak on Tap

December Nasdaq 100 E-Mini futures (NQZ24) are trending up +0.40% this morning as upbeat results from streaming giant Netflix lifted market sentiment, while investors awaited fresh data on the U.S. housing...

NFLX : 772.07 (+1.07%)
AVGO : 179.99 (+0.06%)
WAL : 80.51 (-5.87%)
ALLY : 34.67 (-0.97%)
BSX : 88.05 (-0.02%)
SNA : 325.99 (-0.03%)
DDOG : 125.81 (-1.80%)
NQZ24 : 20,455.75 (-0.31%)
SLB : 42.43 (+1.22%)
ELV : 422.26 (-1.98%)
RF : 23.63 (-0.80%)
ELISA.H.DX : 46.160 (-0.82%)
Catalent Stock Flat Following the Sell Agreement With Ardena

Catalent CTLT recently announced that it has entered into a definitive agreement to sell its oral solids development and small-scale manufacturing facility in Somerset, NJ, to Ardena. Ardena is a Contract...

BSX : 88.05 (-0.02%)
CTLT : 60.18 (-0.18%)
BAX : 36.57 (-0.79%)
DVA : 161.54 (-0.27%)
BDX Stock Up on Robotics Solution Launch to Boost Single-Cell Research

Becton, Dickinson and Company BDX, popularly known as BD, announced the commercial launch of the first in a family of high-throughput, robotics-compatible reagent kits, BD OMICS-One XT Library Preparation...

BSX : 88.05 (-0.02%)
BDX : 240.52 (-1.33%)
BAX : 36.57 (-0.79%)
DVA : 161.54 (-0.27%)
SNN Stock May Gain Following the Co-Marketing Deal With JointVue

Smith & Nephew SNATS SNN recently announced the signing of a co-marketing agreement with JointVue for its patented OrthoSonic 3D Surgery Planning Technology, which is the only ultrasound device currently...

SNN : 29.37 (-0.64%)
BSX : 88.05 (-0.02%)
BAX : 36.57 (-0.79%)
DVA : 161.54 (-0.27%)
MDT Stock Trades Near 52-Week High: Is it a Smart Buy Now?

Following a slump, shares of Medtronic MDT seem to have started to recuperate, possibly banking on a gradually improving investment and research scenario, thanks to the recent monetary policy easing. Closing...

ABT : 116.99 (-2.01%)
BSX : 88.05 (-0.02%)
BDX : 240.52 (-1.33%)
MDT : 91.03 (-1.31%)
Earnings Preview: What To Expect from Boston Scientific's Report

With Boston Scientific gearing up to release its third-quarter earnings later this month, analysts expect double-digit earnings growth.

XLV : 151.33 (-1.18%)
$SPX : 5,853.98 (-0.18%)
BSX : 88.05 (-0.02%)
Zacks.com featured highlights include Royal Caribbean Cruises, Boston Scientific and Monolithic Power Systems

For Immediate ReleaseChicago, IL – October 8, 2024 – Stocks in this week’s article are Royal Caribbean Cruises Ltd. RCL, Boston Scientific Corp. BSX and Monolithic Power Systems, Inc. MPWR.3 Profitable...

BSX : 88.05 (-0.02%)
RCL : 199.91 (-0.02%)
MPWR : 883.26 (-3.60%)
3 Profitable S&P 500 Stocks for the Best Quarter of the Year

After a commendable run in the first nine months of 2024, the S&P 500 is poised to gain in the year’s final three months. The S&P 500 has risen 20.8% in the first three quarters of the year, and historically...

BSX : 88.05 (-0.02%)
RCL : 199.91 (-0.02%)
MPWR : 883.26 (-3.60%)
Reasons to Add Baxter International Stock to Your Portfolio Now

Baxter International BAX is poised for growth, given the demand for its medically essential products, coupled with transformational actions. However, inflationary pressure remains a concern.Shares of this...

UHS : 233.62 (-1.29%)
DGX : 147.37 (-1.52%)
BSX : 88.05 (-0.02%)
BAX : 36.57 (-0.79%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and...

See More

Key Turning Points

3rd Resistance Point 89.53
2nd Resistance Point 89.16
1st Resistance Point 88.61
Last Price 88.05
1st Support Level 87.68
2nd Support Level 87.31
3rd Support Level 86.75

See More

52-Week High 88.79
Last Price 88.05
Fibonacci 61.8% 73.65
Fibonacci 50% 68.97
Fibonacci 38.2% 64.29
52-Week Low 49.15

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar